Video: 2022 M&A Transactional Outlook Part 2

Andre Ulloa provides the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.


More From M&A Healthcare Advisors

Understanding Working Capital and the True-Up Process in Healthcare M&A
Trump’s Executive Order Reversal: Potential Shifts in Home-Care M&A Landscape
Understanding Working Capital and the True-Up Process in Healthcare M&A
Avoiding Deal Breakers: Lessons from Delayed and Failed Transactions
Understanding Working Capital and the True-Up Process in Healthcare M&A
How to Prepare for Buyer Diligence: A Checklist for Healthcare Operators
{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350